摘要:On February 14, 2001, the official journal of the French Republic published a ministerial order modifying the catalogue of reimbursable biological acts (NABM) which adds three new blood tests for the diagnosis and follow up of hepatitis C. In this article, the president and the secretary of the NABM commission explain the relevancy of these new tests for the management of patients infected with the hepatitis C virus, and their appropriateness in light of the international consensus on hepatitis C which took place in Paris in February 1999.
关键词:hepatitis C ; genotype ; serotype ; viral charge